Interplay Between ADP-ribosyltransferases and Essential Cell Signaling Pathways Controls Cellular Responses
Overview
Affiliations
Signaling cascades provide integrative and interactive frameworks that allow the cell to respond to signals from its environment and/or from within the cell itself. The dynamic regulation of mammalian cell signaling pathways is often modulated by cascades of protein post-translational modifications (PTMs). ADP-ribosylation is a PTM that is catalyzed by ADP-ribosyltransferases and manifests as mono- (MARylation) or poly- (PARylation) ADP-ribosylation depending on the addition of one or multiple ADP-ribose units to protein substrates. ADP-ribosylation has recently emerged as an important cell regulator that impacts a plethora of cellular processes, including many intracellular signaling events. Here, we provide an overview of the interplay between the intracellular diphtheria toxin-like ADP-ribosyltransferase (ARTD) family members and five selected signaling pathways (including NF-κB, JAK/STAT, Wnt-β-catenin, MAPK, PI3K/AKT), which are frequently described to control or to be controlled by ADP-ribosyltransferases and how these interactions impact the cellular responses.
Gluth A, Li X, Gritsenko M, Gaffrey M, Kim D, Lalli P Mol Cell Proteomics. 2024; 23(12):100881.
PMID: 39550035 PMC: 11700301. DOI: 10.1016/j.mcpro.2024.100881.
Unleashing viral mimicry: A combinatorial strategy to enhance the efficacy of PARP7 inhibitors.
Manetsch P, Hottiger M Bioessays. 2024; 47(2):e2400087.
PMID: 39502005 PMC: 11755700. DOI: 10.1002/bies.202400087.
Identification of porcine PARP11 as a restricted factor for pseudorabies virus.
Qi C, Zhao D, Wang X, Hu L, Wang Y, Wu H Front Cell Infect Microbiol. 2024; 14:1414827.
PMID: 39445214 PMC: 11496260. DOI: 10.3389/fcimb.2024.1414827.
Crosstalk between BER and NHEJ in XRCC4-Deficient Cells Depending on hTERT Overexpression.
Sergeeva S, Loshchenova P, Oshchepkov D, Orishchenko K Int J Mol Sci. 2024; 25(19).
PMID: 39408734 PMC: 11476898. DOI: 10.3390/ijms251910405.
Delinois L, Sharma A, Ramesh A, Boatright L, Li Q, Xu R Immunohorizons. 2024; 8(8):586-597.
PMID: 39186692 PMC: 11374751. DOI: 10.4049/immunohorizons.2400058.